Regulation, Reimbursement Notes From Turkey

A PharmAsia News update on Turkish biomedical regulatory policies, including a penicillin shortage and an update on a draft patent law.

ISTANBUL – A penicillin shortage continues in Turkey despite efforts to procure supplies for hospitals. Elsewhere, penalties for patent violations outlined in the new draft are the subject of hot discussions among producers of original drugs and generics.

Deva, a major Turkish pharmaceutical company called on the government to “improve” drug prices and update the euro exchange rate...

More from Drug Pricing

More from Scrip

Compass Pathways’ Antidepressant Advances In An Increasingly Tough Psychedelic Market

 
• By 

Psychedelics appear to be in vogue after years of being relegated to alternative medicine. But investor pushback after the highly anticipated release of Phase III trial data by Compass Pathways reveals an increasingly high bar for development.

Eolo Pharma Advances In Obesity With Thermogenesis Approach

 
• By 

Emerging Company Profile: Early-stage biotech Eolo will seek cash and deals for its novel obesity drug SANA after positive Phase I results for weight loss, lean muscle mass preservation and fat mass reduction.

BioMarin’s Roctavian Continues to Shine In Hemophilia A Despite Commercial Woes

 

Roctavian shows durable bleed control and safety over five years, but high costs and access hurdles limit its commercial outlook.